Physician profile
Victor Lu
NPI 1003443888
$2,208.90
in general payments reported to CMS, 2019-2025
9 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $321 · 2023: $111 · 2024: $1,417 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.13 |
| Education | $250.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,343.75 | 2022-2024 | Everest Spinal System, Vitoss, Capri Corpectomy Cage System |
| Medical Device Business Services, INC. | $185.09 | 2024-2025 | Symphony, Teligen |
| Integra Lifesciences Corporation | $151.50 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $121.90 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $108.65 | 2021 | |
| Cerapedics INC. | $98.75 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $87.89 | 2025 | Stealthstation S8 Platform |
| Heron Therapeutics, INC. | $77.51 | 2021 | |
| Silk Road Medical, INC. | $33.86 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.